[ad_1]
American pharmaceutical Pfizer has cut its target for distributing the covid-19 vaccine – which it developed in collaboration with BioNTech – by half this year, The Wall Street Journal and Dow Jones Newswires advanced.
According to the same sources, Pfizer plans to distribute only half of the vaccines initially planned for this year due to supply chain problems.
However, the drug maker expects to supply more than 1 billion doses in 2021.
Results from Pfizer-BioNTech clinical trials, which will begin publishing in scientific journals this week, have shown 95% effectiveness.
According to what was declared yesterday to RTP by the medical director of Pfizer Portugal, Susana Castro Marques, the Pfizer vaccine could arrive in our country on January 1, if approved by the European Medicines Agency on December 29.
.
[ad_2]
Source link
